Mesenchymal stem cell treatment for chronic renal failure

Stem Cell Research and Therapy

Volumn 5, Issue 4, 2014, Pages

  Eirin, Alfonso ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; KIDNEY ARTERY STENOSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; ANIMAL; BIOLOGICAL THERAPY; CELL MOTION; CYTOLOGY; DISEASE MODEL; KIDNEY; KIDNEY FAILURE, CHRONIC; PHYSIOLOGY; REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATION;

EID: 84903962074     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt472     Document Type: Review

References (66)

1. Chronic kidney disease: global dimension and perspectives. V Jha, G Garcia-Garcia, K Iseki, Z Li, S Naicker, B Plattner, R Saran, AY Wang, CW Yang, Lancet 2013 382 260 272 10.1016/S0140-6736(13)60687-X 23727169
2. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. DT Gilbertson, J Liu, JL Xue, TA Louis, CA Solid, JP Ebben, AJ Collins, J Am Soc Nephrol 2005 16 3736 3741 10.1681/ASN.2005010112 16267160 (Pubitemid 46211296)
3. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. M Wyld, RL Morton, A Hayen, K Howard, AC Webster, PLoS Med 2012 9 1001307 10.1371/journal.pmed.1001307 22984353
4. United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. AJ Collins, RN Foley, B Chavers, D Gilbertson, C Herzog, K Johansen, B Kasiske, N Kutner, J Liu, W St Peter, H Guo, S Gustafson, B Heubner, K Lamb, S Li, S Li, Y Peng, Y Qiu, T Roberts, M Skeans, J Snyder, C Solid, B Thompson, C Wang, E Weinhandl, D Zaun, C Arko, SC Chen, F Daniels, J Ebben, et al. Am J Kidney Dis 2012 59 7 e1-e420 22177944
5. Chronic kidney disease: a research and public health priority. N Perico, G Remuzzi, Nephrol Dial Transplant 2012 27 ii19 iii26 22764188
6. Update on the management of chronic kidney disease. JA Rivera, AM O'Hare, GM Harper, Am Fam Physician 2012 86 749 754 23062158
7. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. M Nangaku, Intern Med 2004 43 9 17 10.2169/internalmedicine.43.9 14964574 (Pubitemid 38208370)
8. Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice. T Kaneko, A Shimizu, A Mii, E Fujita, T Fujino, S Kunugi, X Du, T Akimoto, S Tsuruoka, R Ohashi, Y Masuda, Y Iino, Y Katayama, Y Fukuda, Nephron Exp Nephrol 2012 122 23 35 10.1159/000346569 23548779
9. Kidney regeneration. A Benigni, M Morigi, G Remuzzi, Lancet 2010 375 1310 1317 10.1016/S0140-6736(10)60237-1 20382327
10. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. M Dominici, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop, E Horwitz, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
11. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. FE Ezquer, ME Ezquer, DB Parrau, D Carpio, AJ Yanez, PA Conget, Biol Blood Marrow Transplant 2008 14 631 640 10.1016/j.bbmt.2008.01.006 18489988
12. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. RH Lee, MJ Seo, RL Reger, JL Spees, AA Pulin, SD Olson, DJ Prockop, Proc Natl Acad Sci U S A 2006 103 17438 17443 10.1073/pnas.0608249103 17088535 (Pubitemid 44788987)
13. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. S Choi, M Park, J Kim, S Hwang, S Park, Y Lee, Stem Cells Dev 2009 18 521 529 10.1089/scd.2008.0097 18647091
14. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. M Franquesa, E Herrero, J Torras, E Ripoll, M Flaquer, M Goma, N Lloberas, I Anegon, JM Cruzado, JM Grinyo, I Herrero-Fresneda, Stem Cells Dev 2012 21 3125 3135 10.1089/scd.2012.0096 22494435
15. Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. XY Zhu, V Urbieta-Caceres, JD Krier, SC Textor, A Lerman, LO Lerman, Stem Cells 2013 31 117 125 10.1002/stem.1263 23097349
16. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. A Eirin, XY Zhu, JD Krier, H Tang, KL Jordan, JP Grande, A Lerman, SC Textor, LO Lerman, Stem Cells 2012 30 1030 1041 10.1002/stem.1047 22290832
17. Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis. B Ebrahimi, A Eirin, Z Li, XY Zhu, X Zhang, A Lerman, SC Textor, LO Lerman, PLoS One 2013 8 67474 10.1371/journal.pone.0067474 23844014
18. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. UM Fischer, MT Harting, F Jimenez, WO Monzon-Posadas, H Xue, SI Savitz, GA Laine, CS Cox Jr, Stem Cells Dev 2009 18 683 692 10.1089/scd.2008.0253 19099374
19. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. SM Devine, C Cobbs, M Jennings, A Bartholomew, R Hoffman, Blood 2003 101 2999 3001 10.1182/blood-2002-06-1830 12480709 (Pubitemid 36857986)
20. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. D Furlani, M Ugurlucan, L Ong, K Bieback, E Pittermann, I Westien, W Wang, C Yerebakan, W Li, R Gaebel, RK Li, B Vollmar, G Steinhoff, N Ma, Microvasc Res 2009 77 370 376 10.1016/j.mvr.2009.02.001 19249320
21. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. RC Cavaglieri, D Martini, MC Sogayar, IL Noronha, Transplant Proc 2009 41 947 951 10.1016/j.transproceed.2009.01.072 19376395
22. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. C Alfarano, C Roubeix, R Chaaya, C Ceccaldi, D Calise, C Mias, D Cussac, JL Bascands, A Parini, Cell Transplant 2012 21 2009 2019 10.3727/ 096368912X640448 22525800
23. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. AR Chade, XY Zhu, JD Krier, KL Jordan, SC Textor, JP Grande, A Lerman, LO Lerman, Stem Cells 2010 28 1039 1047 10.1002/stem.426 20506499
24. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. MB Herrera, B Bussolati, S Bruno, L Morando, G Mauriello-Romanazzi, F Sanavio, I Stamenkovic, L Biancone, G Camussi, Kidney Int 2007 72 430 441 10.1038/sj.ki.5002334 17507906 (Pubitemid 47237610)
25. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. H Liu, S Liu, Y Li, X Wang, W Xue, G Ge, X Luo, PLoS One 2012 7 34608 10.1371/journal.pone.0034608 22511954
26. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. M Hagiwara, B Shen, L Chao, J Chao, Hum Gene Ther 2008 19 807 819 10.1089/hum.2008.016 18554097
27. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. C Mias, E Trouche, MH Seguelas, F Calcagno, F Dignat-George, F Sabatier, MD Piercecchi-Marti, L Daniel, P Bianchi, D Calise, P Bourin, A Parini, D Cussac, Stem Cells 2008 26 1749 1757 10.1634/stemcells. 2007-1000 18467662
28. A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. C Xinaris, M Morigi, V Benedetti, B Imberti, AS Fabricio, E Squarcina, A Benigni, E Gagliardini, G Remuzzi, Cell Transplant 2013 22 423 436 10.3727/096368912X653246 22889699
29. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. T Yokoo, A Fukui, T Ohashi, Y Miyazaki, Y Utsunomiya, T Kawamura, T Hosoya, M Okabe, E Kobayashi, J Am Soc Nephrol 2006 17 1026 1034 10.1681/ASN.2005101043 16524947
30. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. MB Herrera, B Bussolati, S Bruno, V Fonsato, GM Romanazzi, G Camussi, Int J Mol Med 2004 14 1035 1041 15547670
31. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. M Morigi, B Imberti, C Zoja, D Corna, S Tomasoni, M Abbate, D Rottoli, S Angioletti, A Benigni, N Perico, M Alison, G Remuzzi, J Am Soc Nephrol 2004 15 1794 1804 10.1097/01.ASN.0000128974.07460.34 15213267 (Pubitemid 38822058)
32. Stromal cells protect against acute tubular injury via an endocrine effect. B Bi, R Schmitt, M Israilova, H Nishio, LG Cantley, J Am Soc Nephrol 2007 18 2486 2496 10.1681/ASN.2007020140 17656474 (Pubitemid 47378865)
33. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. F Togel, Z Hu, K Weiss, J Isaac, C Lange, C Westenfelder, Am J Physiol Renal Physiol 2005 289 31 F42 10.1152/ajprenal.00007.2005 15713913 (Pubitemid 40863570)
34. Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment. MS Masoud, SS Anwar, MZ Afzal, A Mehmood, SN Khan, S Riazuddin, J Transl Med 2012 10 243 10.1186/1479-5876-10-243 23217165
35. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. U Kunter, S Rong, Z Djuric, P Boor, G Muller-Newen, D Yu, J Floege, J Am Soc Nephrol 2006 17 2202 2212 10.1681/ASN.2005080815 16790513 (Pubitemid 44141910)
36. Insulin-like growth factor-1 sustains stem cell mediated renal repair. B Imberti, M Morigi, S Tomasoni, C Rota, D Corna, L Longaretti, D Rottoli, F Valsecchi, A Benigni, J Wang, M Abbate, C Zoja, G Remuzzi, J Am Soc Nephrol 2007 18 2921 2928 10.1681/ASN.2006121318 17942965 (Pubitemid 350058399)
37. Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. A Eirin, X Zhang, XY Zhu, H Tang, KL Jordan, JP Grande, AB Dietz, A Lerman, SC Textor, LO Lerman, Nephrol Dial Transplant 2014 29 274 282 10.1093/ndt/gft305 24097799
38. Mesenchymal stem cells: paradoxes of passaging. EH Javazon, KJ Beggs, AW Flake, Exp Hematol 2004 32 414 425 10.1016/j.exphem.2004.02.004 15145209 (Pubitemid 38624325)
39. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. XP Huang, Z Sun, Y Miyagi, H McDonald Kinkaid, L Zhang, RD Weisel, RK Li, Circulation 2010 122 2419 2429 10.1161/CIRCULATIONAHA.110.955971 21098445
40. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. N Eliopoulos, J Stagg, L Lejeune, S Pommey, J Galipeau, Blood 2005 106 4057 4065 10.1182/blood-2005-03-1004 16118325 (Pubitemid 41775910)
41. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. KM Peterson, A Aly, A Lerman, LO Lerman, M Rodriguez-Porcel, Life Sci 2011 88 65 73 10.1016/j.lfs.2010.10.023 21062632
42. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. U Kunter, S Rong, P Boor, F Eitner, G Muller-Newen, Z Djuric, CR van Roeyen, A Konieczny, T Ostendorf, L Villa, M Milovanceva-Popovska, D Kerjaschki, J Floege, J Am Soc Nephrol 2007 18 1754 1764 10.1681/ASN.2007010044 17460140 (Pubitemid 46870312)
43. Sarcoma derived from cultured mesenchymal stem cells. J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, S Bell, L Xia, N Zhou, M Riddle, TM Schroeder, JJ Westendorf, RS McIvor, PC Hogendoorn, K Szuhai, L Oseth, B Hirsch, SR Yant, MA Kay, A Peister, DJ Prockop, WE Fibbe, BR Blazar, Stem Cells 2007 25 371 379 10.1634/stemcells.2005-0620 17038675 (Pubitemid 46232791)
44. Angiomyeloproliferative lesions following autologous stem cell therapy. D Thirabanjasak, K Tantiwongse, PS Thorner, J Am Soc Nephrol 2010 21 1218 1222 10.1681/ASN.2009111156 20558536
45. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. A Eirin, XY Zhu, Z Li, B Ebrahimi, X Zhang, H Tang, MJ Korsmo, AR Chade, JP Grande, CJ Ward, RD Simari, A Lerman, SC Textor, LO Lerman, Arterioscler Thromb Vasc Biol 2013 33 1006 1013 10.1161/ATVBAHA.113.301164 23430615
46. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. RW Yeo, RC Lai, B Zhang, SS Tan, Y Yin, BJ Teh, SK Lim, Adv Drug Deliv Rev 2013 65 336 341 10.1016/j.addr.2012.07.001 22780955
47. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. RC Lai, TS Chen, SK Lim, Regen Med 2011 6 481 492 10.2217/rme.11.35 21749206
48. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. HC Zhang, XB Liu, S Huang, XY Bi, HX Wang, LX Xie, YQ Wang, XF Cao, J Lv, FJ Xiao, Y Yang, ZK Guo, Stem Cells Dev 2012 21 3289 3297 10.1089/scd.2012.0095 22839741
49. Uremia induces functional incompetence of bone marrow-derived stromal cells. H Noh, MR Yu, HJ Kim, JS Jeon, SH Kwon, SY Jin, J Lee, J Jang, JO Park, F Ziyadeh, DC Han, HB Lee, Nephrol Dial Transplant 2012 27 218 225 10.1093/ndt/gfr267 21622994
50. Mesenchymal stem cells derived from adipose tissue are not affected by renal disease. M Roemeling-van Rhijn, ME Reinders, A de Klein, H Douben, SS Korevaar, FK Mensah, FJ Dor, NJ Ijzermans, MG Betjes, CC Baan, W Weimar, MJ Hoogduijn, Kidney Int 2012 82 748 758 10.1038/ki.2012.187 22695328
51. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. MM Lalu, L McIntyre, C Pugliese, D Fergusson, BW Winston, JC Marshall, J Granton, DJ Stewart, PLoS One 2012 7 47559 10.1371/journal.pone.0047559 23133515
52. Mesenchymal stem cells in health and disease. A Uccelli, L Moretta, V Pistoia, Nat Rev Immunol 2008 8 726 736 10.1038/nri2395 19172693
53. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. G Ren, J Su, L Zhang, X Zhao, W Ling, A L'Huillie, J Zhang, Y Lu, AI Roberts, W Ji, H Zhang, AB Rabson, Y Shi, Stem Cells 2009 27 1954 1962 10.1002/stem.118 19544427
54. Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. G Kumar, H Hara, C Long, H Shaikh, D Ayares, DK Cooper, M Ezzelarab, Cytotherapy 2012 14 494 504 10.3109/14653249.2011.651529 22264190
55. Dil and diO: versatile fluorescent dyes for neuronal labelling and pathway tracing. MG Honig, RI Hume, Trends Neurosci 1989 12 333 335 340-341 10.1016/0166-2236(89)90040-4 2480673
56. In vitro differentiation of murine embryonic stem cells toward a renal lineage. SJ Bruce, RW Rea, AL Steptoe, M Busslinger, JF Bertram, AC Perkins, Differentiation 2007 75 337 349 10.1111/j.1432-0436.2006.00149.x 17286599 (Pubitemid 46802153)
57. Carbocyanine dyes with long alkyl side-chains: broad spectrum inhibitors of mitochondrial electron transport chain activity. WM Anderson, D Trgovcich-Zacok, Biochem Pharmacol 1995 49 1303 1311 10.1016/0006-2952(95)00060- D 7763312
58. Stem cells for the treatment of neurological disease. CM Rice, CA Halfpenny, NJ Scolding, Transfus Med 2003 13 351 361 10.1111/j.1365-3148.2003. 00463.x 14651741 (Pubitemid 37549033)
59. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. TF Massoud, SS Gambhir, Genes Dev 2003 17 545 580 10.1101/gad.1047403 12629038 (Pubitemid 36307540)
60. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. DL Kraitchman, M Tatsumi, WD Gilson, T Ishimori, D Kedziorek, P Walczak, WP Segars, HH Chen, D Fritzges, I Izbudak, RG Young, M Marcelino, MF Pittenger, M Solaiyappan, RC Boston, BM Tsui, RL Wahl, JW Bulte, Circulation 2005 112 1451 1461 10.1161/CIRCULATIONAHA.105.537480 16129797 (Pubitemid 41291771)
61. In vivo MR imaging of magnetically labeled mesenchymal stem cells in a rat model of renal ischemia. SI Jung, SH Kim, HC Kim, KR Son, SY Chung, WK Moon, HS Kim, JS Choi, MH Moon, CK Sung, Korean J Radiol 2009 10 277 284 10.3348/kjr.2009.10.3.277 19412516
62. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3 T. H Ittrich, C Lange, F Togel, AR Zander, H Dahnke, C Westenfelder, G Adam, C Nolte-Ernsting, J Magn Reson Imaging 2007 25 1179 1191 10.1002/jmri.20925 17520738 (Pubitemid 46870276)
63. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. ME Reinders, JW de Fijter, H Roelofs, IM Bajema, DK de Vries, AF Schaapherder, FH Claas, PP van Miert, DL Roelen, C van Kooten, WE Fibbe, TJ Rabelink, Stem Cells Transl Med 2013 2 107 111 10.5966/sctm.2012-0114 23349326
64. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. J Tan, W Wu, X Xu, L Liao, F Zheng, S Messinger, X Sun, J Chen, S Yang, J Cai, X Gao, A Pileggi, C Ricordi, JAMA 2012 307 1169 1177 10.1001/jama.2012.316 22436957
65. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. N Perico, F Casiraghi, M Introna, E Gotti, M Todeschini, RA Cavinato, C Capelli, A Rambaldi, P Cassis, P Rizzo, M Cortinovis, M Marasà J Golay, M Noris, G Remuzzi, Clin J Am Soc Nephrol 2011 6 412 422 10.2215/CJN.04950610 20930086
66. Clinicaltrials.gov. http://clinicaltrials.gov